Unequal access to vaccines in the WHO european region during the A(H1N1) influenza pandemic in 2009

Vaccine

Volumn 31, Issue 38, 2013, Pages 4060-4062

  Jorgensen, Pernille ^a   Wasley, Annemarie ^a   Mereckiene, Jolita ^b   Cotter, Suzanne ^b   Weber, J Todd ^c   Brown, Caroline Sarah ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b HEALTH PROTECTION SURVEILLANCE CENTRE   (Ireland)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

A(H1N1)pdm09; Influenza; Pandemic; Vaccines

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; EUROPE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH SURVEY; HUMAN; INFLUENZA A (H1N1); INFLUENZA VACCINATION; PANDEMIC; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; WORLD HEALTH ORGANIZATION;

A(H1N1)PDM09; INFLUENZA; PANDEMIC; VACCINES;

DATA COLLECTION; EUROPE; HEALTHCARE DISPARITIES; HUMANS; IMMUNIZATION PROGRAMS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; VACCINATION;

EID: 84881544370     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.06.082     Document Type: Article

References (22)

1. Flahault A., Zylberman P. Influenza pandemics: past, present and future challenges. Public Health Rev 2010, 32(1):319-340.
2. Collin N., de Radiguès X. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Vaccine 2009, 27(38):5184-5186.
3. WHO supports fair access to influenza A (H1N1) vaccine. Bull World Health Organ 2009, 87(9):653-654.
4. Partridge J., Kieny M.P. Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets. Vaccine 2010, 28(30):4709-4712.
5. World Health Organization Report of the WHO Pandemic Influenza A(H1N1) Vaccine Deployment Initiative 2012, [accessed 11.10.12]. http://whqlibdoc.who.int/publications/2012/9789241564427_eng.pdf.
6. World Health Organization Procedure for assessing the acceptability, in principle, of vaccines for purchase by United Nations agencies 2010, [accessed 21.06.13]. http://www.who.int/immunization_standards/vaccine_quality/pq_revised_procedure_final_1may2012.pdf.
7. European Commission Commission staff working document on lessons learnt from the H1N1 pandemic and on health security in the European Union 2012, [accessed 12.11.12]. http://ec.europa.eu/health/preparedness_response/docs/commission_staff_lessonsh1n1_en.pdf.
8. European Centre for Disease Prevention and Control. Pandemic 2009 evaluations, [accessed 09.12.12]. http://www.ecdc.europa.eu/en/healthtopics/pandemicpreparedness/pandemic2009evaluations/Pages/pandemic%202009%20evaluations.aspx.
9. Mereckiene J., Cotter S., Weber J., Nicoll A., D'Ancona F., Lopalco P., et al. Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe. Euro Surveill 2012, 17(4):pii:20064.
10. VENICE II Consortium Report Pandemic A(H1N1) 2009 Influenza Vaccination Survey, Influenza season 2009/2010 2011, [accessed 20.11.2012]. http://venice.cineca.org/Final_Seasonal_Influenza_Vaccination_Survey_2010.pdf.
11. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009, 360(25):2605-2615.
12. World Health Organization Regional Office for Europe (EuroFlu). [accessed 20.11.12]. http://www.euroflu.org/.
13. European Centre for Disease Prevention and Control., Weekly InfluenzaSurveillance Overview (WISO), [accessed 20.11.12]. http://ecdc.europa.eu/en/healthtopics/seasonalinfluenza/epidemiological%20data/pages/weekly%20influenza%20surveillanceoverview.aspx.
14. World Bank. Atlas method, [accessed 07.10.12]. http://data.worldbank.org/about/country-classifications/world-bank-atlas-method.
15. Yamada T. Poverty, wealth, and access to pandemic influenza vaccines. N Engl J Med 2009, 361(12):1129-1131.
16. Ropero-Álvarez A.M., Whittembury A., Kurtis H.J., dos Santos T., Danovaro-Holliday M.C., Ruiz-Matus C. Pandemic influenza vaccination: lessons learned from Latin America and the Caribbean. Vaccine 2012, 30(5):916-921.
17. World Health Organization Main operational lessons learnt from the WHO pandemic influenza A(H1N1) vaccine deployment initiative 2011, [accessed 24.11.12]. http://whqlibdoc.who.int/publications/2012/9789241564342_eng.pdf.
18. Thompson C.M., Petiot E., Lennaertz A., Henry O., Kamen A.A. Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches. Virol J 2013, 10(141):10-141. 10.1186/1743-422X-10-141.
19. Pica N., Palese P. Toward a universal influenza virus vaccine: prospects and challenges. Annu Rev Med 2013, 64(1):189-202.
20. Friede M., Palkonyay L., Alfonso C., Pervikov Y., Torelli G., Wood D., et al. WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer. Vaccine 2011, 29(Suppl. 1):A2-A7.
21. World Health Organization Pandemic influenza preparedness framework for the sharing of influenza viruses and access to vaccines and other benefits 2011, [accessed 22.11.12]. http://whqlibdoc.who.int/publications/2011/9789241503082_eng.pdf.
22. Pan American Health Organization Operating procedures of the PAHO revolving fund for the purchase of vaccines, syringes, and other related supplies 2011, http://new.paho.org/hq/index.php?option=com_content%38view=article%38id=736%38Itemid=2234.